U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Polyradiculoneuropathy

MedGen UID:
46012
•Concept ID:
C0032587
•
Disease or Syndrome
Synonym: Polyradiculoneuropathies
SNOMED CT: Polyradiculoneuropathy (128078004)
 
Monarch Initiative: MONDO:0006915

Definition

Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (guillain-barre syndrome) and polyradiculoneuropathy, chronic inflammatory demyelinating. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots. [from MONDO]

Professional guidelines

PubMed

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, Attarian S, Blomkwist-Markens PH, Cornblath DR, Eftimov F, Goedee HS, Harbo T, Kuwabara S, Lewis RA, Lunn MP, Nobile-Orazio E, Querol L, Rajabally YA, Sommer C, Topaloglu HA
J Peripher Nerv Syst 2021 Sep;26(3):242-268. Epub 2021 Jul 30 doi: 10.1111/jns.12455. PMID: 34085743
Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach.
Stino AM, Naddaf E, Dyck PJ, Dyck PJB
Muscle Nerve 2021 Feb;63(2):157-169. Epub 2020 Sep 11 doi: 10.1002/mus.27046. PMID: 32914902
POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol 2019 Jul;94(7):812-827. Epub 2019 May 23 doi: 10.1002/ajh.25495. PMID: 31012139

Recent clinical studies

Etiology

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches.
Svačina MKR, Lehmann HC
Curr Pharm Des 2022;28(11):854-862. doi: 10.2174/1381612828666220325102840. PMID: 35339172
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Querol L, Lleixà C
Neurotherapeutics 2021 Oct;18(4):2222-2235. Epub 2021 Sep 21 doi: 10.1007/s13311-021-01117-3. PMID: 34549385Free PMC Article
Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy.
Eftimov F, Lucke IM, Querol LA, Rajabally YA, Verhamme C
Brain 2020 Dec 5;143(11):3214-3224. doi: 10.1093/brain/awaa265. PMID: 33155018Free PMC Article
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database.
Doneddu PE, Cocito D, Manganelli F, Fazio R, Briani C, Filosto M, Benedetti L, Mazzeo A, Marfia GA, Cortese A, Fierro B, Jann S, Beghi E, Clerici AM, Carpo M, Schenone A, Luigetti M, Lauria G, Antonini G, Rosso T, Siciliano G, Cavaletti G, Liberatore G, Santoro L, Peci E, Tronci S, Ruiz M, Cotti Piccinelli S, Toscano A, Mataluni G, Piccolo L, Cosentino G, Sabatelli M, Nobile-Orazio E; Italian CIDP Database study group
J Neurol Neurosurg Psychiatry 2019 Feb;90(2):125-132. Epub 2018 Oct 8 doi: 10.1136/jnnp-2018-318714. PMID: 30297520
Rehabilitation of Guillain-Barré syndrome.
Meythaler JM
Arch Phys Med Rehabil 1997 Aug;78(8):872-9. doi: 10.1016/s0003-9993(97)90203-3. PMID: 9344309

Diagnosis

Autoimmune polyneuropathies.
Naum R, Gwathmey KG
Handb Clin Neurol 2023;195:587-608. doi: 10.1016/B978-0-323-98818-6.00004-2. PMID: 37562888
What Is in the Literature.
Bromberg MB
J Clin Neuromuscul Dis 2022 Dec 1;24(2):68-74. doi: 10.1097/CND.0000000000000429. PMID: 36409336
Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy.
Eftimov F, Lucke IM, Querol LA, Rajabally YA, Verhamme C
Brain 2020 Dec 5;143(11):3214-3224. doi: 10.1093/brain/awaa265. PMID: 33155018Free PMC Article
Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, van Doorn PA
Lancet Neurol 2019 Aug;18(8):784-794. Epub 2019 May 7 doi: 10.1016/S1474-4422(19)30144-9. PMID: 31076244
Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment.
Lehmann HC, Burke D, Kuwabara S
J Neurol Neurosurg Psychiatry 2019 Sep;90(9):981-987. Epub 2019 Apr 16 doi: 10.1136/jnnp-2019-320314. PMID: 30992333

Therapy

Treatment of CIDP.
Fehmi J, Bellanti R, Misbah SA, Bhattacharjee A, Rinaldi S
Pract Neurol 2023 Feb;23(1):46-53. Epub 2022 Sep 15 doi: 10.1136/pn-2021-002991. PMID: 36109154
Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies.
Briani C, Visentin A
Neurotherapeutics 2022 Apr;19(3):874-884. Epub 2022 Mar 28 doi: 10.1007/s13311-022-01222-x. PMID: 35349079Free PMC Article
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Querol L, Lleixà C
Neurotherapeutics 2021 Oct;18(4):2222-2235. Epub 2021 Sep 21 doi: 10.1007/s13311-021-01117-3. PMID: 34549385Free PMC Article
Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?
Allen JA, Gelinas DF, Freimer M, Runken MC, Wolfe GI
J Neurol Sci 2020 Jan 15;408:116497. Epub 2019 Nov 9 doi: 10.1016/j.jns.2019.116497. PMID: 31765922
Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, van Doorn PA
Lancet Neurol 2019 Aug;18(8):784-794. Epub 2019 May 7 doi: 10.1016/S1474-4422(19)30144-9. PMID: 31076244

Prognosis

Acute/chronic inflammatory polyradiculoneuropathy.
Miranda C, Brannagan TH 3rd
Handb Clin Neurol 2023;195:619-633. doi: 10.1016/B978-0-323-98818-6.00026-1. PMID: 37562890
Guillain-Barré syndrome mimics.
Tham SL, Prasad K, Umapathi T
Brain Behav 2018 May;8(5):e00960. Epub 2018 Apr 10 doi: 10.1002/brb3.960. PMID: 29761013Free PMC Article
Peripheral neuropathies.
Hanewinckel R, Ikram MA, Van Doorn PA
Handb Clin Neurol 2016;138:263-82. doi: 10.1016/B978-0-12-802973-2.00015-X. PMID: 27637963
Guillain-Barré syndrome.
Walling AD, Dickson G
Am Fam Physician 2013 Feb 1;87(3):191-7. PMID: 23418763
Guillain-Barré syndrome.
Hughes RA, Cornblath DR
Lancet 2005 Nov 5;366(9497):1653-66. doi: 10.1016/S0140-6736(05)67665-9. PMID: 16271648

Clinical prediction guides

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches.
Svačina MKR, Lehmann HC
Curr Pharm Des 2022;28(11):854-862. doi: 10.2174/1381612828666220325102840. PMID: 35339172
Rituximab in refractory chronic inflammatory demyelinating polyneuropathy.
Muley SA, Jacobsen B, Parry G, Usman U, Ortega E, Walk D, Allen J, Pasnoor M, Varon M, Dimachkie MM
Muscle Nerve 2020 May;61(5):575-579. Epub 2020 Jan 21 doi: 10.1002/mus.26804. PMID: 31922613
POEMS syndrome.
Keddie S, Lunn MP
Curr Opin Neurol 2018 Oct;31(5):551-558. doi: 10.1097/WCO.0000000000000610. PMID: 30138145
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
van Nes SI, Vanhoutte EK, van Doorn PA, Hermans M, Bakkers M, Kuitwaard K, Faber CG, Merkies IS
Neurology 2011 Jan 25;76(4):337-45. doi: 10.1212/WNL.0b013e318208824b. PMID: 21263135
Rehabilitation of Guillain-Barré syndrome.
Meythaler JM
Arch Phys Med Rehabil 1997 Aug;78(8):872-9. doi: 10.1016/s0003-9993(97)90203-3. PMID: 9344309

Recent systematic reviews

Guidelines for Neuroprognostication in Adults with Guillain-Barré Syndrome.
Busl KM, Fried H, Muehlschlegel S, Wartenberg KE, Rajajee V, Alexander SA, Creutzfeldt CJ, Fontaine GV, Hocker SE, Hwang DY, Kim KS, Madzar D, Mahanes D, Mainali S, Meixensberger J, Sakowitz OW, Varelas PN, Westermaier T, Weimar C
Neurocrit Care 2023 Jun;38(3):564-583. Epub 2023 Mar 25 doi: 10.1007/s12028-023-01707-3. PMID: 36964442Free PMC Article
Triggers of Guillain-Barré Syndrome: Campylobacter jejuni Predominates.
Finsterer J
Int J Mol Sci 2022 Nov 17;23(22) doi: 10.3390/ijms232214222. PMID: 36430700Free PMC Article
Efficacy of intravenous immunoglobulin in autoimmune neurological diseases. Literature systematic review and meta-analysis.
Morales-Ruiz V, Juárez-Vaquera VH, Rosetti-Sciutto M, Sánchez-Muñoz F, Adalid-Peralta L
Autoimmun Rev 2022 Mar;21(3):103019. Epub 2021 Dec 15 doi: 10.1016/j.autrev.2021.103019. PMID: 34920107
Efficacy of rituximab treatment in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.
Hu J, Sun C, Lu J, Zhao C, Lin J
J Neurol 2022 Mar;269(3):1250-1263. Epub 2021 Jun 12 doi: 10.1007/s00415-021-10646-y. PMID: 34120208
Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP).
Querol L, Crabtree M, Herepath M, Priedane E, Viejo Viejo I, Agush S, Sommerer P
J Neurol 2021 Oct;268(10):3706-3716. Epub 2020 Jun 24 doi: 10.1007/s00415-020-09998-8. PMID: 32583051Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • MeSH
      Related Medical Subject Headings
    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...